9th 3D Tissue Models Summit 2024
Evvnt Promotion / evvnt
21.05.2024 - 23.05.2024 Omni Parker House, 60 School St, 02108 Boston, Massachusetts, USA
Time: 9:00 AM - 2:00 PM
Temas de la conferencia
The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.
The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2224592-3?pid=4832
Speakers: Anastasia Korolj, PhD, Chemical and Biomedical Engineer, Harvard medical school/Massachusetts General Hospital, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Inc., and more
Brochure: https://go.evvnt.com/2224592-3?pid=4832
Speakers: Anastasia Korolj, PhD, Chemical and Biomedical Engineer, Harvard medical school/Massachusetts General Hospital, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Inc., and more
Información e inscripción:
https://go.evvnt.com/2224592-2?pid=4832
Mr. Alex Domingo
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
